Literature DB >> 23086985

Cell-based interventions for therapeutic angiogenesis: review of potential cell sources.

Robert A Brenes1, Mackenzie Bear, Caroline Jadlowiec, Matthew Goodwin, Peter Hashim, Clinton D Protack, Kenneth R Ziegler, Xin Li, Lynn S Model, Wei Lv, Michael J Collins, Alan Dardik.   

Abstract

Alternative therapies are currently being developed to treat patients with chronic limb ischemia who are unable to be revascularized in order to avoid amputation. Cell-based therapy using mononuclear cells is gaining attention as many clinical trials are currently underway. We review cell differentiation along with the different potential cell sources for use in therapeutic angiogenesis.

Entities:  

Mesh：

Year:  2012        PMID： 23086985      PMCID： PMC3670829          DOI： 10.1258/vasc.2011.201205

Source DB:  PubMed          Journal:  Vascular        ISSN： 1708-5381            Impact factor:   1.285


  76 in total

1.  Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.

Authors:  Carmen Urbich; Christopher Heeschen; Alexandra Aicher; Elisabeth Dernbach; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

Review 2.  Hematopoiesis in the yolk sac: more than meets the eye.

Authors:  Kathleen E McGrath; James Palis
Journal:  Exp Hematol       Date:  2005-09       Impact factor: 3.084

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

4.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

5.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Authors:  U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

6.  Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice.

Authors:  J E Dick; M C Magli; D Huszar; R A Phillips; A Bernstein
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

7.  A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells.

Authors:  A M Wu; J E Till; L Siminovitch; E A McCulloch
Journal:  J Cell Physiol       Date:  1967-04       Impact factor: 6.384

8.  Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.

Authors:  Pingping Huang; Shangzhu Li; Mingzhe Han; Zhijian Xiao; Renchi Yang; Zhong Chao Han
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

9.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

10.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307
View more
  11 in total

Review 1.  A Murine Model of Hind Limb Ischemia to Study Angiogenesis and Arteriogenesis.

Authors:  Jun Yu; Alan Dardik
Journal:  Methods Mol Biol       Date:  2018

Review 2.  Biological therapies in otology.

Authors:  A Roemer; H Staecker; S Sasse; T Lenarz; A Warnecke
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

3.  [Biological therapies in otology. German version].

Authors:  A Roemer; H Staecker; S Sasse; T Lenarz; A Warnecke
Journal:  HNO       Date:  2017-07       Impact factor: 1.284

4.  CD34+ circulating cells display signs of immune activation in patients with acute coronary syndrome.

Authors:  Lisa Riesinger; Michael Saemisch; Markus Nickmann; Heiko Methe
Journal:  Heart Vessels       Date:  2018-07-12       Impact factor: 2.037

Review 5.  Hypoxia-inducible factor as an angiogenic master switch.

Authors:  Takuya Hashimoto; Futoshi Shibasaki
Journal:  Front Pediatr       Date:  2015-04-24       Impact factor: 3.418

6.  A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier.

Authors:  Alok Sharma; Hemangi Sane; Nandini Gokulchandran; Pooja Kulkarni; Sushant Gandhi; Jyothi Sundaram; Amruta Paranjape; Akshata Shetty; Khushboo Bhagwanani; Hema Biju; Prerna Badhe
Journal:  Stem Cells Int       Date:  2015-02-18       Impact factor: 5.443

Review 7.  Concise review: evidence for CD34 as a common marker for diverse progenitors.

Authors:  Laura E Sidney; Matthew J Branch; Siobhán E Dunphy; Harminder S Dua; Andrew Hopkinson
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

8.  EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation.

Authors:  C C Lachaud; J López-Beas; B Soria; A Hmadcha
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469

9.  Biohybrid cochlear implants in human neurosensory restoration.

Authors:  Ariane Roemer; Ulrike Köhl; Omid Majdani; Stephan Klöß; Christine Falk; Sabine Haumann; Thomas Lenarz; Andrej Kral; Athanasia Warnecke
Journal:  Stem Cell Res Ther       Date:  2016-10-07       Impact factor: 6.832

10.  An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability.

Authors:  Alok Sharma; Hemangi Sane; Nandini Gokulchandran; Suhasini Pai; Pooja Kulkarni; Vaishali Ganwir; Maitree Maheshwari; Ridhima Sharma; Meenakshi Raichur; Samson Nivins; Prerna Badhe
Journal:  Stem Cell Res Ther       Date:  2018-01-31       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.